Report on the 10th Neurological Disorders Summit (NDS-2025)
The 10th Neurological Disorders Summit (NDS-2025) organized by United Scientific Group was held from April 28, 2025 to April 30, 2025 in Hybrid mode (In-person & Virtual). 123 attendees from more than 25 countries presented at NDS-2025 over 3 days with 2 Plenary and 3 keynote lectures, 70 oral and 25 poster and 1 Sponsor presentations. Of the Plenary speakers, opening talk given by Dr. Giulio Maria Pasinetti, Icahn School of Medicine at Mount Sinai, USA on “Role of the Immune T Regulatory Cells in Mood Disorders and Alzheimer’s Disease Phenotype as a Therapeutic Target in Altered Gut-brain Axis Cross-talking”. Dr. Hossein Ansari, University of California, USA & Ali Totonchi, Metro Health Medical Center, USA presented “Role disease Deactivation of Peripheral Nerves for the Management of Migraine Headache”. Dr. Jin Jun Luo, from Temple University, USA Lectured “The Link Between Vitamin D Deficiency and Peripheral Neuropathy: A Risk Factor?”. Dr. Rajendra D. Badgaiyan, from Texas Tech University Health Sciences Center, USA on “A Novel Approach to Diagnose and Treat Neurological Disorders”. Dr. Niketa A. Patel from JAH VA Hospital and University of South Florida, USA on “Intranasal Delivery of Human Adipose Stem Cells Derived Exosomes for Treatment of Traumatic Brain Injury “ and last keynote talk given by Dr. Kenneth Blum (Co-Chairman of NDS-2025), Western University College of Medicine, USA on “Gwas & Pharmacogenomic Evidence for Genetic and Epigenetic Correlates of Reward Deficiency Syndrome(Rds) : A New Era in Evidence Based Data”.
One invited talk given by Dr. Yuko Harada, Kawasaki Municipal Ida Hospital, Japan on “Nonconvulsive Status Epilepticus”.
Oral and poster presentations were carried out on various topics including "Alzheimer’s Disease, Dementia and Mild Cognitive Impairment", "Stroke & Neurotrauma", "Autism and Neurodevelopmental Disorders", "Neurological Disorders: Diagnostics, Treatments and Rehabilitation", "Stroke, Migraine & Headache". Those presentations demonstrated the first hand findings of basic and/or clinical researches which were well appreciated by the participants.
We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thanks to our sponsor Kaneka for their support.
The proceeding of the conference will be published in the Journal of Neurology & Experimental Neuroscience (JNEN).
The Summit has provided an exciting opportunity to showcase research, modern technologies and the service of the industry to the global audience on neurological disorders. The 11th Neurological Disorders Summit will be held on July 06-08, 2026 in Boston, MA. We look forward to seeing your presence with your research findings at the next Summit.
